Suppr超能文献

在一个患有Bardet-Biedl 综合征的克什米尔家庭中发现一种新型纯合错义突变(c.443A>T:p.N148I)。

Identification of a Novel Homozygous Missense (c.443A>T:p.N148I) Mutation in in a Kashmiri Family with Bardet-Biedl Syndrome.

机构信息

Department of Biotechnology, University of Azad Jammu and Kashmir, P.O. Box 13100, Muzaffarabad, Pakistan.

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 11 Mandalay Road, Singapore 308232.

出版信息

Biomed Res Int. 2021 Feb 23;2021:6626015. doi: 10.1155/2021/6626015. eCollection 2021.

Abstract

BACKGROUND

Bardet-Biedl syndrome (BBS) is a rare autosomal recessive inherited disorder with distinctive clinical feature such as obesity, degeneration of retina, polydactyly, and renal abnormalities. The study was aimed at finding out the disease-causing variant/s in patients exhibiting clinical features of BBS.

METHODS

The identification of disease-causing variant was done by using whole exome sequencing on Illumina HiSeq 4000 platform involving the SeqCap EZ Exome v3 kit (Roche NimbleGen). The identified variant was further validated by Sanger sequencing.

RESULTS

WES revealed a novel homozygous missense mutation (NM_031885: c.443A>T:p.N148I) in exon 3 of the gene. Sanger sequencing confirmed this variant as homozygous in both affected subjects and heterozygous in obligate parents, demonstrating autosomal recessive inheritance pattern. To the best of our knowledge, this variant was not present in literature and all publically available databases. The candidate variant is predicted to be pathogenic by a set of in-silico softwares.

CONCLUSION

Clinical and genetic spectrum of BBS and BBS-like disorders is not completely defined in the Pakistani as well as in Kashmiri population. Therefore, more comprehensive genetic studies are required to gain insights into genotype-phenotype associations to facilitate carrier screening and genetic counseling of families with such disorders.

摘要

背景

Bardet-Biedl 综合征(BBS)是一种罕见的常染色体隐性遗传性疾病,具有独特的临床特征,如肥胖、视网膜变性、多指畸形和肾脏异常。本研究旨在发现表现出 BBS 临床特征的患者中的致病变异。

方法

使用 Illumina HiSeq 4000 平台上的全外显子组测序(WES),涉及 SeqCap EZ Exome v3 试剂盒(罗氏 NimbleGen),确定致病变异。通过 Sanger 测序进一步验证鉴定的变异。

结果

WES 显示基因第 3 外显子中存在一种新的纯合错义突变(NM_031885:c.443A>T:p.N148I)。Sanger 测序证实这一变异在两个受影响的个体中均为纯合子,在强制性父母中为杂合子,表现出常染色体隐性遗传模式。据我们所知,该变异在文献和所有公共可用数据库中均不存在。候选变异被一组计算机软件预测为致病性。

结论

BBS 及 BBS 样疾病在巴基斯坦及克什米尔人群中的临床及遗传谱尚未完全确定。因此,需要进行更全面的遗传研究,以深入了解基因型-表型相关性,从而为这些疾病的携带者筛查和遗传咨询提供便利。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5828/7925018/324625ba256a/BMRI2021-6626015.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验